From: Empowering Continuing Medical Education (CME) in India: leveraging Kern’s instructional design model
Items | [Before training] | [After training] | p value |
---|---|---|---|
Please rate your knowledge on the concept of EPA on a scale of 1 to 5. (1 = very low, 5 = very high) | 1.66 ± 0.99 | 3.82 ± 0.75 | < 0.0001 |
Please rate your ability to distinguish between EPA and competency on a scale of 1 to 5. (1 = no ability, 5 = strong ability) | 1.58 ± 0.93 | 3.69 ± 0.79 | < 0.0001 |
Please rate your knowledge on elements of EPA description on a scale of 1 to 5. (1 = very low, 5 = very high) | 1.54 ± 0.99 | 3.78 ± 0.70 | < 0.0001 |
Please rate your ability to validate EPA on a scale of 1 to 5. (1 = no ability, 5 = strong ability) | 1.38 ± 0.90 | 3.59 ± 0.75 | < 0.0001 |
Please rate your knowledge on current progress in the development of EPAs for MD Biochemistry program on a scale of 1 to 5. (1 = very low, 5 = very high) | 1.45 ± 0.90 | 3.71 ± 0.72 | < 0.0001 |
CME improved my confidence in Developing and Validating EPAs for MD Biochemistry program | 86.2% | ||
Overall effectiveness of the CME (5-point Likert scale) | 4.45 ± 0.59 |